Remove Bioethics Remove COVID-19 Vaccine Remove Governance Remove Nurses
article thumbnail

How to Fairly Allocate Scarce COVID-19 Therapies

Bill of Health

The Delta variant led the federal government to resume control over mAb supply and promulgate allocation guidelines. Older and medically vulnerable people who continue to face high risk of COVID-19 illness after vaccination should not be asked to wait in line behind adults who refused vaccines.

COVID-19 211
article thumbnail

Learning from the ‘COVID War’

Bill of Health

This respectability, I argue, means that their recommendations are too narrow to protect Americans, much less the populations of the Global South, from pandemics ahead (barring unexpectedly marvelous advances in vaccine breadth and rapidity of deployment). Some have also served as public health officials and/or professors.

article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

. #2: Moderna, funded with nearly $1 billion in taxpayer dollars to develop a COVID-19 vaccine, sets the highest prevailing market price for the product. The controversy here is that this was the highest price set although the company received 100% of the development costs for the vaccine covered by the U.S.